| Citation: | LIHua, BIANYao-yao, YANGLi-li, ZHOUXi, ZENGLi. Research Progress on Anti-Tumor Effect of Ligustrazine in Digestive System Neoplasms[J]. Journal of Nanjing University of traditional Chinese Medicine, 2020, 36(3): 424-427.
|
| [1] |
奚胜艳，岳利峰，李卫东，等.《黄帝内经》胃本源理论临床意义及对消化系统肿瘤防治的作用[J].中华中医药杂志，2011，26(6):1267-1270.
|
| [2] |
李忠，王沛. 临床肿瘤学[M]. 沈阳：辽宁科学技术出版社， 2002:3-4.
|
| [3] |
ZHENG Z， LI Z， CHEN S， et al. Tetramethylpyrazine attenuates TNFα-induced iNOS expression in human endothelial cells: Involvement of Syk-mediated activation of PI3K-IKK-IκB signaling pathways [J]. Exp Cell Res， 2013(319): 2145-2151.
|
| [4] |
LIN KH， KUO WW， JIANG AZ， et al. Tetramethylpyrazine ameliorated hypoxia-induced myocardial cell apoptosis via HIF-1α/JNK/p38 and IGFBP3/BNIP3 inhibition to upregulate PI3K/Akt survival signaling[J]. Cell Physiol Biochem Int J Exper Cell Physiol Biochem Pharmacol， 2015， 36(1):334.
|
| [5] |
ZHAO YK， LIU Y， CHEN KJ. Mechanisms and clinical application of tetramethylpyrazine (an interesting natural compound isolated from Ligusticum wallichii): Current status and perspective[J]. Oxidat Med Cell Longev， 2016， 2016:1-9.
|
| [6] |
LIANG SD ， XU CS ， ZHOU T， et al. Tetramethylpyrazine inhibits ATP-activated currents in rat dorsal root ganglion neurons[J]. Brain Res， 2005，1040(1/2):92-97.
|
| [7] |
YAN J ， ZOU K ， LIU X ， et al. Hyperexcitability and sensitization of sodium channels of dorsal root ganglion neurons in a rat model of lumber disc herniation[J]. Europ Spine J， 2016， 25(1):177-185.
|
| [8] |
WANG Y， FU Q， ZHAO W. Tetramethylpyrazine inhibits osteosarcoma cell proliferation via downregulation of NF-κB in vitro<\i> and in vivo<\i>[J]. Mol Med Rep， 2013， 8(4):984-988.
|
| [9] |
ZHENG CY， XIAO W， ZHU MX， et al.Inhibition of cyclooxygenase-2 by tetramethylpyrazine and its effects on A549 cell invasion and metastasis[J]. Int J Oncol， 2012， 40(6):2029-2037.
|
| [10] |
JIA Y， WANG Z， ZANG A， et al. Tetramethylpyrazine inhibits tumor growth of lung cancer through disrupting angiogenesis via BMP/Smad/Id-1 signaling[J]. Int J Oncol， 2016， 48(5):2079.
|
| [11] |
CAO J， MIAO Q， ZHANG J， et al. Inhibitory effect of tetramethylpyrazine on hepatocellular carcinoma: Possible role of apoptosis and cell cycle arrest[J]. J Biol Regul Homeost Agent， 2015， 29(2):297.
|
| [12] |
张加军， 邢国辉， 王继伟，等. 川芎嗪对人肝癌HepG2细胞的影响及与突变型p53蛋白表达的影响[J]. 中国中医药现代远程教育， 2013， 11(17):157-159.
|
| [13] |
JI AJ， LIU SL， JU WZ， et al. Anti-proliferation effects and molecular mechanisms of action of tetramethypyrazine on human SGC-7901 gastric carcinoma cells[J]. Asian Pac J Cancer Prev， 2014， 15(8):3581-3586.
|
| [14] |
万慧芳， 余波， 涂硕，等. 川芎嗪对人结肠癌LoVo细胞增殖与凋亡的影响[J]. 中成药， 2014， 36(7):1367-1371.
|
| [15] |
BERASAIN C， PERUGORRIA MJ， LATASA MU， et al. The epidermal growth factor receptor: A link between inflammation and liver cancer[J]. Exp Biol Med， 2009， 234(7):713-725.
|
| [16] |
PAN HC， JIANG Q， YU Y， et al.Quercetin promotes cell apoptosis and inhibits the expression of MMP-9 and fibronectin via the AKT and ERK signalling pathways in human glioma cells[J]. Neurochem Int， 2015， 80:60-71.
|
| [17] |
PANDA PK， MUKHOPADHYAY S， DAS DN， et al. Mechanism of autophagic regulation in carcinogenesis and cancer therapeutics[J]. Semin Cell Devel Biol， 2015， 39:43-55.
|
| [18] |
BI L， YAN X， CHEN W， et al.Antihepatocellular carcinoma potential of tetramethylpyrazine induces cell cycle modulation and mitochondrial-dependent apoptosis: Regulation of p53 signaling pathway in HepG2 cells in vitro<\i>[J]. Integr Cancer Ther， 2016， 15(2):226.
|
| [19] |
AOUACHERIA A， BAGHDIGUIAN S， LAMB HM， et al. Connecting mitochondrial dynamics and life-or-death events via Bcl-2 family proteins[J]. Neurochem Int， 2017， 109:141-161.
|
| [20] |
CAO J， MIAO Q， MIAO S， et al. Tetramethylpyrazine (TMP) exerts antitumor effects by inducing apoptosis and autophagy in hepatocellular carcinoma[J]. Int Immunopharmacol， 2015， 26(1):212-220.
|
| [21] |
MOLDOGAZIEVA NURBUBU T， LUTSENKO SERGEY V， TERENTIEV ALEXANDER A. Reactive oxygen and nitrogen species-induced protein modifications: Implication in carcinogenesis and anticancer therapy[J]. Cancer Res， 2018， 78: 6040-6047.
|
| [22] |
CHUNG YM， BAE YS， LEE SY. Molecular ordering of ROS production， mitochondrial changes， and caspase activation during sodium salicylate-induced apoptosis[J]. Free Radic Biol Med， 2003， 34(4):434-442.
|
| [23] |
YI B， LIU D， HE M， et al. Role of the ROS/AMPK signaling pathway in tetramethylpyrazine-induced apoptosis in gastric cancer cells[J]. Oncol Lett， 2013， 6(2):583-589.
|
| [24] |
孙晓， 尹中普， 尹红梅. 川芎嗪对人肝癌HepG-2细胞体外侵袭和迁移的影响[J]. 实用肝脏病杂志， 2018，21(1):31-34.
|
| [25] |
柴瑾， 宋恺， 沈钢. 川芎嗪对肿瘤细胞的VEGF表达和肿瘤血管内皮细胞生长的影响[J]. 国际中医中药杂志， 2009， 31(1):71-72.
|
| [26] |
李雷宇， 张俊华， 张银旭，等. 川芎嗪抗大肠癌sw620裸鼠移植瘤血管生成及抑瘤机制的实验研究[J]. 东南大学学报(医学版)， 2010， 29(5):519-523.
|
| [27] |
魏志霞. 川芎嗪对肝癌多药耐药株SMMC-7721/ADM的逆转作用[J]. 江苏医药， 2005， 31(5):371-372.
|
| [28] |
WANG XB， WANG SS， ZHANG QF， et al. Inhibition of tetramethylpyrazine on P-gp， MRP2， MRP3 and MRP5 in multidrug resistant human hepatocellular carcinoma cells[J]. Oncol Rep， 2010， 23(1):211.
|
| [29] |
杨伟霞， 陆少锋， 贾宁，等. 川芎嗪对人胃癌细胞株SGC-7901/ADR增殖、凋亡和MDR1、GST-π表达的影响[J]. 中华中医药学刊， 2015，33(8):2008-2010.
|
| [30] |
吴风青.川芎嗪对结肠癌多药耐药性基因表达的抑制[J].辽宁中医药大学学报，2011，13(3):145-146.
|
| [31] |
高婷， 凌斌， 赵卫东， 等. 卵巢恶性肿瘤免疫状态与转录因子T-bet/GATA3相关性及川芎嗪干预研究[J]. 南京中医药大学学报， 2007， 23(2):85-88.
|
Copyright © Journal of Nanjing University of traditional Chinese Medicine
Sponsored by：Nanjing University of traditional Chinese MedicineAddress：No.138 xianlin Avenue, Qixia District, Nanjing cityChina Pos：210023
Tel：025-85811935Email：xb@njucm.edu.cn
Supported by:
Beijing Renhe Information Technology Co., Ltd.
DownLoad: